A protein that keeps people - and their skeletons - organized
11/16/2013
Most people think that their planners or their iPhones keep them organized, when proteins such as liver kinase b1 (Lkb1) actually have a lot more to do with it.
Malaria drug as effective in low doses
11/15/2013
A new study finds that lower doses of the drug primaquine are as effective at preventing transmission of malaria as standard doses.Primaquine targets the transmission stages of the malaria parasite, the gametocytes, and is considered an important tool for malaria elimination.
Adelaide: Health professionals should be better equipped to address the psychosexual needs of gynaecological cancer patients, according to research to be presented at an international cancer conference on 14th November.
FDA approves Imbruvica for rare blood cancer
11/15/2013
The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer.MCL is a rare form of non-Hodgkin lymphoma and represents about 6 percent of all non-Hodgkin lymphoma cases in the United States.
Geranylgeraniol suppresses the viability of human prostate cancer cells and HMG CoA reductase
11/15/2013
Researchers at Texas Woman's University have shown that a diterpene geranylgeraniol found in linseed oil, Cedrela toona wood oil, sucupira branca fruit oil and more recently, annatto seed oil, suppressed the viability of human DU145 prostate carcinoma cells via cell cycle arrest at the G1 phase and the initiation of apoptosis.
Johns Hopkins researchers report that the deletion of any single gene in yeast cells puts pressure on the organism's genome to compensate, leading to a mutation in another gene.
Personalized therapy using antitumor T cells from a patient's own cancer
11/15/2013
Patients with tumors that contain increased numbers of T lymphocytes generally survive longer than those with tumors without T-cell involvement, suggesting that T cells with potent antitumor function naturally exist in cancer and control tumor progression.
New study shows that womb cancer can be detected early using easily accessible body fluids
11/15/2013
A new study, funded by The Eve Appeal and published this week in the open access journal PLOS Medicine[i], has the potential to change the cancer landscape by being able to accurately identify individuals with early stage womb cancer using easily accessible body fluids.
Potential therapy for some cancers, rheumatoid arthritis following identification of common molecule
11/15/2013
A molecule that helps cells stick together is significantly over-produced in two very different diseases - rheumatoid arthritis and a variety of cancers, including breast and brain tumors, concludes a new study. The scientists who made the discovery also found candidate drugs to inhibit the molecule, cadherin-11, one of which is already in a clinical trial.
Researchers test bandaging for breast cancer-related swollen arm
11/15/2013
As a complication of treatment, breast cancer patients may develop swelling in the arm, called lymphedema, which can last a long time.But there's no difference if simple compression bandages or a complicated daily lymphatic massage are used as treatment, McMaster University researchers have found.